AI assistant
Sending…
BioCardia, Inc. — Director's Dealing 2018
Mar 22, 2018
35081_dirs_2018-03-22_727b947f-6393-4f81-b919-f74667e2823d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioCardia, Inc. (BCDA)
CIK: 0000925741
Period of Report: 2018-02-01
Reporting Person: Altman Peter (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-01 | Stock Option (right to buy) | $2.60 | A | 400000 | Acquired | 2028-02-01 | Common stock (400000) | Direct |
Footnotes
F1: The option vests and becomes exercisable as to 1/48th of the shares on March 1, 2018 and each monthly anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
More from BioCardia, Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 2
Director's Dealing
2026
Mar 27
Regulatory Filings
2026
Mar 24
Registration Form
2026
Mar 24